 |
|
 |
 |
|
| |
References:
1. |
Grandemange, E., Claerebout, E., Genchi, C., and Franc, M., (2007). Field evaluation
of the efficacy and the safety of a combination of oxantel/pyrantel/praziquantel in the
treatment of naturally acquired gastrointestinal nematode and/or cestode infestations in
dogs in Europe. Vet. Parasitol. 145:94-99. |
|
|
2. |
Cadiergues, M.C., and Franc, M., (1994).
Pyrantel in pets – a review. Rev. Med. Vet 145:449-453. |
|
|
3. |
Martin, R.J., Clark, C.L.,
Trailovic, S.M., Robertson, A.P., (2004). Oxantel is an N-type (methyridine and nicotine)
agonist not an L-type (levamisole and pyrantel) agonist: classification of cholinergic
anthelmintics in Ascaris. Int. J. Parasitol 34: 1083-1090. |
|
|
4. |
Day, T. A., Bennett, J. L.,
Pax, R. A., (1992). Praziquantel- the enigmatic antiparasitic. Parasitol. Today 8 (10):
342-344 |
|
|
5. |
Trial reference number Vetoquinol study 9302 T4F1.
|
|
|
| |
|
|
|
|
 |
 |
 |
 |
|
